CAS: 100-82-3; (3-Fluorophenyl)Methanamine

该化合物是一种有机化合物,其特征是存在附于苯基胺结构的氟原子;其特征是相对于矿类组的元体位置,一个苯环与氟原子相替代;该化合物一般无色可粉黄黄色液体或固态,取决于其纯度和温度;其有独特的矿味,并且有机溶剂中可溶解;氟原子的存在可影响其再活动性和物理特性,例如与其他苯基胺相比,沸点和极性. 3-Fluorobenzylamine经常用于有机合成,并可作为制药和农用化学品生产的中间体.重要的是要谨慎地处理这一化合物,因为如果吸入或浸入,可能会对健康造成危害,而且在其使用过程中应当采取适当的安全措施.此外,其化学行为可能受到周围分子中存在功能组的影响,例如沸点和极性等,与其他苯基胺相比. 3-Flurobenzylamine经常用于有机合成合成,并可作为生产药物和农用化学的中间体.重要的是,因为如果吸入或浸入,则可能对对健康造成健康风险的危险危险风险,因为如果吸入,则在使用过程中可能构成适当的危害,那么在使用时会对其健康危害.

结构式图片

相似化合物

658-25-3 455-37-8 90390-27-5

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号403-54-3 3-氟苯甲腈 | CAS号456-48-4 3-氟苯甲醛 | CAS号456-42-8 间氟氯苄 | CAS号456-48-4 3-氟苯甲醛 | CAS号180207-86-7 N-(3-氟苄基)甲酰胺 | CAS号1979-49-3 (E)-1-氟-3-(2-硝基乙烯基)苯 | CAS号63351-94-0 3-氟苄基异硫氰酸酯 | CAS号102422-56-0 3-氟苯甲基异氰酸酯 | CAS号324-57-2 2-(3-fluorophen... | CAS号1629-09-0 N-苯基-3-氟苯甲酰胺 | CAS号36458-13-6 3-fc6h4ch2n(h)so2cf3 | CAS号554-68-7 三乙胺盐酸盐 | CAS号67023-51-2 N-[(3-fluorophe...

合成工艺路线路线简述

    3-氟苯腈置于水,C16H11Brmnn3O3,Sodium Hydroxide体系中,用 四氢呋喃,甲醇 用作溶剂,化学反应 24.0H,反应生成3-氟苄胺
    参考文献:含锰配合物的苯并咪唑片段催化酮和腈的氢化硅烷化
    标题:含锰配合物的苯并咪唑片段催化酮和腈的氢化硅烷化
    摘要:报道了一种新的双齿(nn)-Mn(i)配合物的合成,并研究了其对酮和腈还原的催化活性.在比较苯并咪唑配体负载的其他各种mn(i)配合物的反应性时,观测到带有6-甲基吡啶和苯并咪唑片段的mn(i)配合物对酮的单氢化硅烷化和腈的二氢化硅烷化表现出最高的催化活性.使用该方案,将广泛的酮选择性地还原为相应的甲硅烷基醚.在不饱和酮的情况下,观测到羰基在烯烃键上的化学选择性还原.另外,使用该配合物还实现了几个腈的选择性二氢硅烷化.用自由基清除剂进行的机械研究表明,在催化反应过程中自由基种类的参与.Mn(i)配合物与苯基硅烷的化学计量反应揭示了新的mn(i)配合物的形成.
    Doi:10.1016/j.Tet.2020.131439

    专利信息


    专利号:WO-2021260722-A1
    优先权日:2020-06-21
    标 题:Design, synthesis of novel oxyindole inhibitors of denv rna dependent rna polymerase
    发明人:GUNDLA RAMBABU; ASTHANA SHAILENDRA; BHATTACHARYYA SANKAR; MADDIPATI VENKATANARAYANA CHOWDARY; MITTAL LOVIKA; KAUR JASKARAN; RAWAT YOGITA
    权利人:TRANSLATIONAL HEALTH SCIENCE AND TECH INSTITUTE; GANDHI INSTITUTE OF TECH AND MANAGEMENT
    摘要:The present invention is drawn to novel compounds of formula I, II and III, including any conformational isomeric form, salts and solvates for inhibition of DENV RNA dependent and RNA polymerase. The present invention also discloses a process of synthesis of the compounds, compositions comprising the said compounds and use of the compounds and treatment comprising the compounds of the present invention.

    专利号:US-9708317-B2
    优先权日:2013-11-25
    标 题 :Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivatives
    发明人:ZAMBON ALFONSO; NICULESCU-DUVAZ DAN; CHUBB RICHARD; SPRINGER CAROLINE JOY
    权利人:CANCER RES TECH LTD; INST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE); OXY SCIENT LTD; THE INST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
    摘要:The present invention pertains generally to the field of organic chemical synthesis, and in particular to certain methods for the synthesis of 8-(4-aminophenyoxy)-4H-pyrido[2,3-b]pyrazin-3-one and related compounds (denoted herein as (3)) from 4-(4-aminophenyoxy)pyridine-2,3-diamine and related compounds (denoted herein as (1)), by reaction with glyoxylic acid (denoted herein as (2)). The compounds (3) are useful in the synthesis of known anti-cancer agents, such as 1-(5-tert-butyl-2-(4-methyl-phenyl)-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea.

    专利号:US-2025129021-A1
    优先权日:2023-09-19
    标 题:Small molecule protein synthesis modulators
    发明人:GYGI DAVID; BAHMANYAR SOGOLE SAMI; HAMANN LAWRENCE
    权利人:INTERDICT BIO INC
    摘要:The present disclosure provides compounds of the formulae herein (e.g., Formula (I), Formula (V)), and pharmaceutically acceptable salts thereof, which are useful for modulating protein synthesis (e.g., modulating synthesis of BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D). The present disclosure also provides pharmaceutical compositions and kits comprising the compounds, or pharmaceutically acceptable salts thereof, and methods of treating or preventing diseases or disorders (e.g., diseases or disorders associated with BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D) by administering to a subject in need thereof the compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof.

    专利号:US-7109377-B2
    优先权日:1996-10-16
    标 题:Synthesis of combinatorial libraries of compounds reminiscent of natural products
    发明人:SCHREIBER STUART L; SHAIR MATTHEW D; TAN DEREK S; FOLEY MICHAEL A; STOCKWELL BRENT R
    权利人:HARVARD COLLEGE
    摘要:The present invention provides complex compounds reminiscent of natural products and libraries thereof, as well as methods for their production. The inventive compounds and libraries of compounds are reminiscent of natural products in that they contain one or more stereocenters, and a high density and diversity of functionality. In general, the inventive libraries are synthesized from diversifiable scaffold structures, which are synthesized from readily available or easily synthesizable template structures. In certain embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from a shikimic acid based epoxyol template. In other embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from the pyridine-based template isonicotinamide. The present invention also provides a novel ortho-nitrobenzyl photolinker and a method for its synthesis. Furthermore, the present invention provides methods and kits for determining one or more biological activities of members of the inventive libraries. Additionally, the present invention provides pharmaceutical compositions containing one or more library members.

    专利号:US-9018371-B2
    优先权日:2007-03-07
    标 题 :Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient
    发明人:JEONG LAK SHIN; KIM HEA OK; JACOBSON KENNETH A; CHOE SEUNG AH
    权利人:JEONG LAK SHIN; KIM HEA OK; JACOBSON KENNETH A; CHOE SEUNG AH; FM THERAPEUTICS CO LTD; US OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES THE OFFICE OF TECHNO
    摘要:Disclosed are adenosine derivatives, methods for the synthesis thereof, and pharmaceutical compositions for the prevention and treatment of inflammatory diseases, comprising the same as an active ingredient. The adenosine derivatives have high binding affinity and selectivity for adenosine receptors, especially for A 3 adenosine receptors and act as A 3 adenosine receptor antagonists, and exhibit anti-inflammatory activity. Thus, the adenosine derivatives are useful in the prevention and treatment of inflammatory diseases.

    专利号:US-2003092064-A1
    优先权日:2001-04-05
    标题 :System for the synthesis of spatially separated libraries of compounds and methods for the use thereof
    发明人:READER JOHN C
    权利人:MILLENNIUM PHARM INC
    摘要:Featured is an apparatus useful for preparing combinatorial libraries of compounds in a parallel fashion so that the individual compounds of the library are spatially separate and the position of each compound of the library in the apparatus is known. Moreover, the apparatus is useful for the preparation of combinatorial libraries of compounds where the library is constructed from three or more building blocks, e.g., three, four, five, six or seven building blocks, resulting in a three, four, five, six or seven dimensional combinatorial library. Also featured are related methods for the preparation of three, four, five, six or seven dimensional combinatorial libraries of compounds using the apparatus of the present invention.
    南阳君浩化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nyjunhaochem.com
    企业联系电话:0377-63569226、63562680👤
    📞南阳君浩化工有限公司 ⚠️参考联系方式
    联系人:段总
    电话:0377-63569226、63562680
    手机:13643998972
    传真:0377-63569208
    邮箱:nyjh@nyjunhaochem.com
    通信地址: 河南省南阳市桐柏县化工产业集聚区创业路8号
    邮编: 474750
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:河南省南阳市桐柏县化工产业集聚区创业路8号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    台州市创源工业技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.tzchemical.com
    企业联系电话:13757609826;0576-85289468👤
    📞台州市创源工业技术有限公司 ⚠️参考联系方式
    联系人:徐经理
    电话:13757609826;0576-85289468
    手机:13757609826
    传真:0576-85289468
    邮箱:sales@tzchemical.com
    通信地址: 浙江省临海市清化路7号大洋基地一区十七幢
    邮编: 317000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省临海市清化路7号大洋基地一区十七幢
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: R F Kaltenbach Rd, Et Al. Dpc 681 And Dpc 684: Potent, Selective Inhibitors Of Human Immunodeficiency Virus Protease Active Against Clinically Relevant Mutant Variants. Antimicrob Agents Chemother. 2001 Nov;45(11):3021-8.

    合成参考文献


    摘要:Bagal, D. B.; Bhanage, B. M., Science of Synthesis: Catalytic Reduction in Organic Synthesis, (2018) 2, 385.
    摘要:Bagal, D. B.; Bhanage, B. M., Science of Synthesis: Catalytic Reduction in Organic Synthesis, (2018) 2, 387.
    摘要:L.F. Blackwell, A. Fischer, I.J. Miller, R.D. Topson, and J. Vaughan. J. Chem. Soc. 1964, 3588.
    摘要:Sharma, U.; Parmar, D.; Sumit; Manisha, Science of Synthesis: Knowledge Updates, (2024) 2, 16.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知